Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$451K Sell
2,937
-9,181
-76% -$1.4M 0.21% 239
2020
Q1
$1.7M Sell
12,118
-1,580
-12% -$236K 0.77% 6
2019
Q4
$2.09M Buy
13,698
+9,212
+205% +$1.35M 0.58% 16
2019
Q3
$648K Sell
4,486
-128
-3% -$19.1K 0.12% 248
2019
Q2
$687K Sell
4,614
-707
-13% -$94.4K 0.12% 236
2019
Q1
$681K Sell
5,321
-51
-0.9% -$6K 0.12% 241
2018
Q4
$574K Buy
+5,372
New +$600K 0.12% 250
2018
Q2
Sell
-28,126
Closed -$2.63M 389
2018
Q1
$2.63M Buy
+28,126
New +$2.56M 0.65% 19

Other funds holding STE

361 Capital's STE Position: Q2 2020 in Review

361 Capital reduced its Steris (STE) stake by 76% in Q2 2020, selling an estimated $1.4M and leaving 2,937 shares worth $451K. The position accounts for 0.21% of the portfolio, ranked #239.

361 Capital first reported a position in STE in Q1 2018 and has held it in 8 quarters since. The position peaked at $2.63M in Q1 2018. 576 funds tracked by Wall St. Rank hold STE as of Q2 2020.

  • 361 Capital held 2,937 shares of Steris worth $451K as of Q2 2020.
  • 361 Capital sold 9,181 Steris shares in Q2 2020, an estimated $1.4M.
  • Steris made up 0.21% of 361 Capital's portfolio in Q2 2020, its #239 holding.
  • 361 Capital first reported a position in Steris in Q1 2018 and has held it in 8 quarters since.
  • 361 Capital's Steris position peaked at $2.63M in Q1 2018.
  • 576 funds tracked by Wall St. Rank held Steris as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.